Michael Krel is a highly experienced professional in the biotechnology sector, currently serving as a Board Member for various companies including Verley, Microphyt, Meiogenix, Elicit Plant, enginzyme, and AFYREN. With a long tenure as a Partner at Sofinnova Partners since March 2013, Michael focuses on early-stage investments in industrial biotechnology and renewable chemistry. Michael has also held significant leadership roles, such as the CEO of EnobraQ, which aims to utilize CO2 as an industrial fermentation feedstock. Educational qualifications include a Ph.D. in organic chemistry from both École Polytechnique and ICSN.
This person is not in the org chart
This person is not in any teams
This person is not in any offices